These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12661415)

  • 1. [Intravenous immunoglobulin preparations for treatment of lymphoreticular malignancies in adults].
    Frydecka I
    Postepy Hig Med Dosw; 2002; 56 Suppl():53-8. PubMed ID: 12661415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Criteria of the eligibility of patients for treatment with intravenous normal human immunoglobulin].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():7-9. PubMed ID: 17893961
    [No Abstract]   [Full Text] [Related]  

  • 3. Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
    Srinivasan S; Schiffer CA
    Leuk Res; 2009 Apr; 33(4):561-4. PubMed ID: 18676017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary deficiencies of humoral immunity in hematology: what management?].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():1. PubMed ID: 17893958
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.
    Raanani P; Gafter-Gvili A; Paul M; Ben-Bassat I; Leibovici L; Shpilberg O
    Leuk Lymphoma; 2009 May; 50(5):764-72. PubMed ID: 19330654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes.
    Bonilla FA
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):803-19, ix. PubMed ID: 18940575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
    Naumann F; Weingart O; Kruse E; Schulz H; Bohlius J; Hülsewede H; Engert A;
    J Natl Cancer Inst; 2006 Aug; 98(16):E2. PubMed ID: 16912255
    [No Abstract]   [Full Text] [Related]  

  • 8. Lenalidomide for the treatment of B-cell malignancies.
    Chanan-Khan AA; Cheson BD
    J Clin Oncol; 2008 Mar; 26(9):1544-52. PubMed ID: 18285605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma.
    Thürmann PA; Sonnenburg C; Valentová K; Gregora E; Freischläger F; Lissner R
    Eur J Clin Pharmacol; 2001 Jun; 57(3):235-41. PubMed ID: 11497339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.
    Winkelstein A; Jordan PS
    Clin Rev Allergy; 1992; 10(1-2):39-58. PubMed ID: 1606523
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of infection in patients with B cell defects: focus on intravenous immunoglobulin.
    Yap PL
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S372-5. PubMed ID: 8274603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of immunoglobulins].
    Nicodemo AC; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(1):46-52. PubMed ID: 1307403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
    Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
    Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid malignancies: a decade and a half of dramatic improvements in outcome.
    Zelenetz AD
    Clin Lymphoma Myeloma; 2008 Aug; 8 Suppl 4():S126-7. PubMed ID: 18952542
    [No Abstract]   [Full Text] [Related]  

  • 15. Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia.
    Barton JC
    Am J Hematol; 2003 Nov; 74(3):205-7. PubMed ID: 14587053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed B-cell malignancies.
    Dowlati A; Lazarus HM; Hartman P; Jacobberger JW; Whitacre C; Gerson SL; Ksenich P; Cooper BW; Frisa PS; Gottlieb M; Murgo AJ; Remick SC
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5929-35. PubMed ID: 14676117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon manifestations of common malignancies: case 2. Chronic lymphocytic leukemia and multiple myeloma in the same patient.
    Devi VL; Prabhash K; Malathi M; Madhumathi DS; Bapsy PP
    J Clin Oncol; 2004 Aug; 22(15):3192-3. PubMed ID: 15284273
    [No Abstract]   [Full Text] [Related]  

  • 19. Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone.
    Nanda M; Nanda A; Al-Sabah H; Dvorak R; Alsaleh QA
    Int J Dermatol; 2007 Jul; 46(7):767-9. PubMed ID: 17614814
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin.
    Ostronoff M; Ostronoff F; Coutinho M; Calixto R; Souto Maior AP; Sucupira A; Florencio R; Tagliari C
    Bone Marrow Transplant; 2006 Apr; 37(8):797-8. PubMed ID: 16518425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.